Role of biomarkers for prediction of infection after cancer surgery

Procalcitonin and C-reactive protein as early predictor of infection in elective gastrointestinal cancer surgery- a prospective observational study

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/12/016695

Enrollment

130

Registered

2018-12-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C211- Malignant neoplasm of anal canal Health Condition 2: C15- Malignant neoplasm of esophagus Health Condition 3: C23- Malignant neoplasm of gallbladder Health Condition 4: C22- Malignant neoplasm of liver and intrahepatic bile ducts Health Condition 5: C26- Malignant neoplasm of other and ill-defined digestive organs Health Condition 6: C25- Malignant neoplasm of pancreas Health Condition 7: C19- Malignant neoplasm of rectosigmoidjunction Health Condition 8: C20- Malignant

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: all patients above 18 years age with gastrointestinal cancer are eligible.

Exclusion criteria

Exclusion criteria: immunocompromised patient patient with pre-operative infection. patient recieving steroid treatment. renal failure

Design outcomes

Primary

Measure	Time frame
Accuracy of CRP and PCT to detect IAI, in terms of Area under the curve, determination of threshold value and corresponding sensitivity, specificity values and positive and negative predictive valuesTimepoint: february, 2020	—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactDr A Anandhi

JIPMER

anandhiramesh76@yahoo.in9487781661

Outcome results